1. Home
  2. TNXP vs FUNC Comparison

TNXP vs FUNC Comparison

Compare TNXP & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • FUNC
  • Stock Information
  • Founded
  • TNXP 2007
  • FUNC 1900
  • Country
  • TNXP United States
  • FUNC United States
  • Employees
  • TNXP N/A
  • FUNC N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • FUNC Major Banks
  • Sector
  • TNXP Health Care
  • FUNC Finance
  • Exchange
  • TNXP Nasdaq
  • FUNC Nasdaq
  • Market Cap
  • TNXP 197.9M
  • FUNC 235.5M
  • IPO Year
  • TNXP N/A
  • FUNC N/A
  • Fundamental
  • Price
  • TNXP $15.12
  • FUNC $38.28
  • Analyst Decision
  • TNXP Buy
  • FUNC
  • Analyst Count
  • TNXP 1
  • FUNC 0
  • Target Price
  • TNXP $70.00
  • FUNC N/A
  • AVG Volume (30 Days)
  • TNXP 778.7K
  • FUNC 18.2K
  • Earning Date
  • TNXP 11-10-2025
  • FUNC 10-20-2025
  • Dividend Yield
  • TNXP N/A
  • FUNC 2.70%
  • EPS Growth
  • TNXP N/A
  • FUNC 56.67
  • EPS
  • TNXP N/A
  • FUNC 3.84
  • Revenue
  • TNXP $10,299,000.00
  • FUNC $83,662,000.00
  • Revenue This Year
  • TNXP $14.79
  • FUNC $16.22
  • Revenue Next Year
  • TNXP $933.49
  • FUNC $7.42
  • P/E Ratio
  • TNXP N/A
  • FUNC $10.01
  • Revenue Growth
  • TNXP N/A
  • FUNC 17.79
  • 52 Week Low
  • TNXP $6.76
  • FUNC $24.66
  • 52 Week High
  • TNXP $130.00
  • FUNC $42.50
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 35.51
  • FUNC 64.72
  • Support Level
  • TNXP $13.70
  • FUNC $35.17
  • Resistance Level
  • TNXP $18.25
  • FUNC $38.69
  • Average True Range (ATR)
  • TNXP 1.28
  • FUNC 0.78
  • MACD
  • TNXP 0.07
  • FUNC 0.29
  • Stochastic Oscillator
  • TNXP 26.08
  • FUNC 89.17

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

Share on Social Networks: